Excessive level of parathyroid hormone may induce the reduction of recombinant human erythropoietin effect on renal anemia.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Mineral and Electrolyte Metabolism

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 7565462
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recombinant human erythropoietin and renal anemia: molecular biology, clinical efficacy, and nervous system effects.

  1991cited by this paper
• The role of aluminium and parathyroid hormone in erythropoietin resistance in haemodialysis patients.

  1991cited by this paper
• Treatment with recombinant human erythropoietin in patients with aluminum overload and hyperparathyroidism.

  1990cited by this paper
• Effect of secondary hyperparathyroidism on the anaemia of end-stage renal failure: in vivo and in vitro studies.

  1983cited by this paper
• Effect of parathyroid hormone on osmotic fragility of human erythrocytes.

  1982cited by this paper
• Effect of parathyroid hormone on erythropoiesis.

  1981cited by this paper
• Effect of parathyroidectomy on anemia in chronic renal failure.

  1979cited by this paper
• Uremic syndrome in man: new evidence for parathormone as a multisystem neurotoxin.

  1979cited by this paper
• Anemia and secondary hyperparathyroidism.

  1978cited by this paper
• Anemia in primary hyperparathyroidism.

  1977cited by this paper
• Is parathyroid hormone a uremic toxin?

  1977cited by this paper

• Role of inflammation, nutritional status and body mass index in the development of resistance to erythropoiesis-stimulating agents (ESAs) in patients under regular hemodialysis

  2024cites this paper
• Factors Contributing to Erythropoietin Hyporesponsiveness in Patients on Long-Term Continuous Ambulatory Peritoneal Dialysis: A Cross-Sectional Study

  2015cites this paper
• Anaemia Management in Chronic Kidney Disease

  2014cites this paper
• Pathophysiological mechanisms of anemia in diabetic nephropathy

  2013cites this paper
• Effect of Alfacalcidol on Anemia in Renal Failure Patients

  2011influential citation
• THE ROLE OF SECONDARY HYPERPARATHYROIDISM IN ANEMIA OF END STAGE RENAL DISEASE

  2003cites this paper
• Intensification of Anemia by Secondary Hyperparathyroidism in Hemodialysis Patients

  2003cites this paper
• Is secondary hyperparathyroidism a significant cause of renal anemia

  2002cites this paper
• Role of uremic toxins in exacerbating anemia in renal failure.

  2001cites this paper
• Human parathyroid hormone does not influence human erythropoiesis in vitro.

  1998cites this paper
• Effects of excess PTH on nonclassical target organs.

  1997cites this paper
• The required dose of erythropoietin during renal anaemia treatment is related to the degree of impairment in erythrocyte deformability.

  1997cites this paper
• Benefits of calcitriol therapy and serum phosphorus control in dogs and cats with chronic renal failure. Both are essential to prevent of suppress toxic hyperparathyroidism.

  1996cites this paper
• The effect of parathyroidectomy on hematocrit and erythropoietin dose in patients on hemodialysis.

  1996cites this paper
• SECONDARY HYPERPARATHYROIDISM ON THE TREATMENT OF ANEMIA IN PATIENTS UNDERGOING

  year unknowncites this paper